Cobalt silicide nanoparticles in mesoporous silica SBA-15 were successfully prepared by metal-organic chemical vapor deposition of a single-source precursor and were characterized by nitrogen physorption, X-ray diffraction, temperature-programmed reduction, temperature-programmed desorption, and transmission electron microscopy. The catalytic hydrogenation of naphthalene on the cobalt silicide nanoparticles in mesoporous silica was investigated in a fixed-bed reactor at 340 °C under 4.0 MPa hydrogen pressure. No cobalt silicide was observed in the mesoporous silica without calcination because of the hydrolysis of Co(SiCl 3 )(CO) 4 . Highly dispersed and evenly distributed cobalt silicide particles with diameters of 2−4 nm could be formed by adsorption and reduction of Co(SiCl 3 )(CO) 4 in the mesoporous silica with calcination above 500 °C. The cobalt silicide loading in the mesoporous silica depended on both the amount of precursor provided and the amount of hydroxyl groups in the mesoporous silica. A 8.3% CoSi/SBA-15 sample showed lower conversion and higher selectivity to tetralin (about 100%) in the naphthalene hydrogenation, while a 16.1% CoSi/SBA-15 sample showed a higher catalytic activity up to 87% and a lower selectivity to tetralin (35%) than other CoSi/SBA-15 samples, which may be due to the size effect and the strong interaction of CoSi and support.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: